Re: Comparison of Pathological and Oncologic Outcomes of Favorable Risk Gleason Score 3 + 4 and Low Risk Gleason Score 6 Prostate Cancer: Considerations for Active Surveillance: D. J. Gearman, A. Morlacco, J. C. Cheville, L. J. Rangel and R. J. Karnes J Urol 2018; 199: 1188–1195. Journal of Urology October 2018;200(4):905
Date
10/01/2018
DOI
10.1016/j.juro.2018.05.079Scopus ID
2-s2.0-85052540185 (requires institutional sign-in at Scopus site)
Author List
Iczkowski KA